(Bloomberg) -- The $160 billion fund behind Ozempic-maker Novo Nordisk A/S says President Donald Trump’s tariff war has created so much economic uncertainty that it now sees little likelihood it ...

Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said it’s continuing to prepare for a possible initial public offering, with no exact timing set yet for a sale.

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. When should six drugs count ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Cloud provider De Novo experienced a power outage at its data center in Ukraine on Saturday, April 26. Reported by local and tech publications, including dev.ua, the data center outage occurred during ...

Telehealth providers will soon offer more affordable access to weight loss drug Wegovy, according to manufacturer Novo Nordisk. The drugmaker announced Tuesday it had reached an agreement with ...

A woman was fined more than £11,000 by a parking firm that expects drivers to buy a ticket within five minutes. Hannah Robinson, 21, was fined by Excel Parking for failing to make the purchase ...